Overview

4 out of 5 (1 Reviews)

Credits

1.00

Post Assessment Questions

6

Start Date

1 Sep 2023

Last Review Date

7 Mar 2024

Expiration Date

31 Aug 2026

Estimated Time To Finish

60 Minutes


 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

Mycetoma is characterized by a progressive and chronic granulomatous infection affecting the skin and subcutaneous tissue. Mycetoma can be classified as "eumycetoma" when it is caused by fungi or "actinomycetoma" when caused by bacteria in the order Actinomycetes. Therefore, eumycetoma is a deep fungal infection of the skin and subcutaneous tissue commonly caused by the filamentous fungi Madurella mycetomatis. Eumycetoma is characterized by a deep granulomatous inflammation, resulting in the formation of grains, which destroy tissues such as muscles, bones, joints, and tendons. Clinical features include painless plaques with hard woody swelling, discharging sinuses, and characteristic granular grains or microcolonies. The World Health Organization (WHO) recognizes mycetoma as a neglected tropical disease, which primarily affects individuals in tropical and subtropical regions who come into direct contact with soil.

The foot is often prone to fungal infections due to exposure to fungi in the soil via skin trauma. This type of infection usually enters through skin damage and causes symptoms in the feet, hands, or legs. Managing eumycetoma poses significant challenges and necessitates a prolonged treatment regimen that often combines systemic antifungal therapy for an extended duration with surgical interventions. Neglected infections may lead to severe tissue destruction, underscoring the medical significance and treatment complexities associated with eumycetoma. This activity provides a comprehensive review of the evaluation, diagnosis, and treatment of eumycetoma, highlighting the pivotal role of the interprofessional healthcare team in facilitating early diagnosis and treatment for patients affected by this condition.


UAN: JA4008338-0000-23-6343-H01-P

Target Audience

This activity has been designed to meet the educational needs of physicians, physician associates, nurses, pharmacists, and nurse practitioners.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Identify the characteristic clinical features of eumycetoma, including painless plaques, hard woody swelling, and discharging sinuses.

  • Screen individuals in endemic regions for signs and symptoms of eumycetoma, especially those with a history of barefoot walking and soil exposure.

  • Select appropriate antifungal agents for systemic antifungal therapy and dosage regimens tailored to the severity and duration of eumycetoma infection.

  • Collaborate with interprofessional healthcare teams, including dermatologists, infectious disease specialists, and surgeons, to optimize patient care and outcomes and ensure comprehensive monitoring for relapse or complications.

Pharmacy Activity Type:
Disease/Drug Therapy Related


Disclosures

StatPearls, LLC requires everyone who influences the content of an educational activity to disclose relevant financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflict(s) of interest have been mitigated. Hover over contributor names for financial disclosures. Others involved in planning this educational activity have no relevant financial relationships to disclose.

Commercial Support: This activity has received NO commercial support.

Continuing Education Accreditation Information

In support of improving patient care, StatPearls, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Pharmacists: StatPearls, LLC designates this activity for a maximum of 1.00 ACPE credit(s). (UAN: JA4008338-0000-23-6343-H01-P ). Pharmacists should only claim credit commensurate with the extent of their participation in the activity.

Please consult your professional licensing board for information on the applicability and acceptance of continuing education credit for this activity.

Method of Participation and Credit

  1. Register for the activity.    
  2. Review the target audience, learning objectives, and disclosure information.
  3. Study the educational content of the enduring material.
  4. Choose the best answer to each activity test question. To receive credit and a certificate, you must pass the test questions with a minimum score of 100%.
  5. Complete the post-activity assessment survey.

If you have concerns regarding the CE/CME system, please contact support@statpearls.com.

Disclaimer

This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Faculty may discuss investigational products or off-label uses of products regulated by the FDA. Readers should verify all information before employing any therapies described in this educational activity.

The information provided for this activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The information presented does not necessarily reflect the views of StatPearls or any commercial supporters of educational activities on statpearls.com. StatPearls expressly disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through a participant's misunderstanding of the content.

Unapproved Uses of Drugs/Devices: In accordance with FDA requirements, the audience is advised that information presented in this continuing education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA-approved package insert for each drug/device for full prescribing/utilization information.

Cancellation Policy: Please see the cancellation policy. StatPearls, LLC reserves the right to cancel any course due to unforeseen circumstances.

 

 
 

Reviews

Dr.NIRMALA M. on 12/1/2022

Unlimited Pharmacist CE

Stay up to date on the latest medical knowledge with 6673 CE activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7924.5 hours of CE.

6 Month Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$119 per half year per user

1 Year Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$199 per 1 year per user